Business, energy, technology, markets and global industry news from Business News Today

DELTA TEEN

PharmaDeviceNews DELTA TEEN
Editorial infographic highlighting LEO Pharma’s 21 dermatology research posters covering Anzupgo, Spevigo and Adbry, featuring skin tissue illustrations, clinical research imagery and key highlights on adolescent FDA review, clinical evidence and commercial growth prospects.
Pharma & Biotech

Why LEO Pharma is investing in real-world evidence for difficult dermatological diseases

LEO Pharma presents 21 dermatology posters covering Anzupgo, Spevigo and Adbry. Examine adolescent FDA review, clinical data and growth prospects.

Read More
Representative image: A dermatologist examines chronic hand eczema as LEO Pharma’s ESCD 2026 data highlight the condition’s impact on work, school participation and daily life.
Pharma & Biotech

Why LEO Pharma is shifting the chronic hand eczema debate from skin clearance to life impact

New analyses from the DELTA FORCE and DELTA TEEN programmes extend the chronic hand eczema discussion beyond skin clearance. The findings could strengthen the clinical and economic case for delgocitinib, although real-world effectiveness, adolescent regulation and treatment access remain important tests.

Read More